Verona Pharma PLC
NASDAQ:VRNA
Verona Pharma PLC
NASDAQ:VRNA
Price:
86
USD
Market Closed
Market Cap:
$7.4B
Cash Flow Statement
Cash Flow Statement
Verona Pharma PLC
Verona Pharma PLC
Currency: USD
| Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||
| Net Income |
(62)
|
(65)
|
(86)
|
(84)
|
(38)
|
(56)
|
(59)
|
(55)
|
(82)
|
(69)
|
(61)
|
(52)
|
(51)
|
(54)
|
(63)
|
(125)
|
(154)
|
(173)
|
(164)
|
(81)
|
|
| Depreciation & Amortization |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Stock-Based Compensation |
10
|
22
|
31
|
36
|
34
|
25
|
20
|
16
|
14
|
14
|
15
|
17
|
19
|
19
|
19
|
30
|
32
|
41
|
74
|
94
|
|
| Other Non-Cash Items |
16
|
22
|
31
|
33
|
28
|
23
|
19
|
19
|
20
|
19
|
17
|
17
|
16
|
17
|
19
|
34
|
40
|
56
|
91
|
106
|
|
| Cash Taxes Paid |
(6)
|
0
|
0
|
9
|
11
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
1
|
1
|
10
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
3
|
3
|
7
|
10
|
20
|
25
|
|
| Change in Working Capital |
0
|
(2)
|
(9)
|
(17)
|
(19)
|
(2)
|
10
|
6
|
(9)
|
(11)
|
(9)
|
(19)
|
(14)
|
(14)
|
(14)
|
37
|
9
|
(6)
|
(48)
|
(98)
|
|
| Cash from Operating Activities |
(44)
N/A
|
(45)
-2%
|
(64)
-41%
|
(68)
-7%
|
(28)
+58%
|
(33)
-17%
|
(29)
+12%
|
(29)
+2%
|
(69)
-143%
|
(60)
+14%
|
(51)
+15%
|
(53)
-4%
|
(48)
+10%
|
(50)
-6%
|
(58)
-16%
|
(54)
+7%
|
(104)
-93%
|
(122)
-18%
|
(120)
+2%
|
(72)
+40%
|
|
| Investing Cash Flow | |||||||||||||||||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
|
| Other Items |
11
|
10
|
10
|
(0)
|
(3)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
11
N/A
|
10
-8%
|
10
N/A
|
(0)
N/A
|
(3)
-1 082%
|
(0)
+100%
|
(0)
N/A
|
(0)
-300%
|
(0)
+25%
|
(0)
N/A
|
(0)
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
(0)
N/A
|
(0)
-181%
|
(0)
N/A
|
(1)
-1 189%
|
(1)
-89%
|
(1)
+3%
|
|
| Financing Cash Flow | |||||||||||||||||||||
| Net Issuance of Common Stock |
254
|
200
|
0
|
0
|
0
|
1
|
0
|
0
|
151
|
151
|
153
|
153
|
3
|
2
|
1
|
1
|
4
|
5
|
10
|
15
|
|
| Net Issuance of Debt |
(0)
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
15
|
15
|
15
|
39
|
29
|
99
|
99
|
70
|
193
|
123
|
|
| Other |
(15)
|
(13)
|
(13)
|
(16)
|
(3)
|
(7)
|
(8)
|
(5)
|
(14)
|
(15)
|
42
|
43
|
53
|
52
|
(9)
|
88
|
77
|
175
|
65
|
(32)
|
|
| Cash from Financing Activities |
239
N/A
|
192
-19%
|
192
N/A
|
189
-2%
|
(51)
N/A
|
(6)
+88%
|
(7)
-12%
|
(4)
+40%
|
137
N/A
|
141
+3%
|
210
+49%
|
211
+0%
|
71
-66%
|
93
+30%
|
21
-77%
|
188
+792%
|
181
-4%
|
251
+39%
|
267
+7%
|
105
-61%
|
|
| Change in Cash | |||||||||||||||||||||
| Effect of Foreign Exchange Rates |
(0)
|
1
|
1
|
0
|
1
|
(0)
|
(1)
|
(2)
|
(3)
|
(1)
|
(0)
|
1
|
2
|
1
|
0
|
(0)
|
2
|
(0)
|
0
|
2
|
|
| Net Change in Cash |
205
N/A
|
158
-23%
|
139
-12%
|
122
-13%
|
(82)
N/A
|
(40)
+52%
|
(37)
+7%
|
(35)
+6%
|
65
N/A
|
79
+22%
|
159
+100%
|
159
+0%
|
26
-84%
|
44
+71%
|
(37)
N/A
|
134
N/A
|
79
-41%
|
128
+63%
|
147
+14%
|
33
-77%
|
|
| Free Cash Flow | |||||||||||||||||||||
| Free Cash Flow |
(44)
N/A
|
(45)
-2%
|
(64)
-41%
|
(68)
-6%
|
(28)
+59%
|
(33)
-18%
|
(29)
+12%
|
(29)
+2%
|
(69)
-143%
|
(60)
+14%
|
(51)
+15%
|
(53)
-3%
|
(48)
+10%
|
(50)
-6%
|
(58)
-16%
|
(54)
+7%
|
(104)
-93%
|
(123)
-18%
|
(121)
+1%
|
(74)
+39%
|
|
Switch to:
Switch to:
See Also
Discover More
